FEBS Letters

Number of times cited: 76

• Lutz Birnbaumer, From GTP and G proteins to TRPC channels: a personal account, Journal of Molecular Medicine, 10.1007/s00109-015-1328-5, 93, 9, (941-953), (2015).
  Crossref
• Klaus Starke, Es kann die Spur von unseren Erdetagen—on pharmacologists and pharmacology, Naunyn-Schmiedeberg's Archives of Pharmacology, 380, 5, (465), (2009).
  Crossref
• In Sup Kil, Jin Hyup Lee, Ai Hyang Shin and Jeen-Woo Park, Glycation-induced inactivation of NADP+-dependent isocitrate dehydrogenase: implications for diabetes and aging, Free Radical Biology and Medicine, 37, 11, (1765), (2004).
  Crossref
• Jan F. Klinker and Roland Seifert, Interaction of the Retinal G-Protein Transducin with Uracil Nucleotides, Biochemical and Biophysical Research Communications, 262, 2, (341), (1999).
  Crossref
• M.F Heath, R.W Farndale, C.S Napthine, L.J Hayes and R.J Evans, Molecular Mechanism of Resistance of Equine (Equus caballus) Platelets to α2-Adrenergic Regulation, Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 118, 4, (889), (1997).
  Crossref
• Jan F. Klinker and Roland Seifert, Functionally nonequivalent interactions of guanosine 5′-triphosphate, inosine 5′-triphosphate, and xanthosine 5′-triphosphate with the retinal G-protein, transducin, and with Gi-proteins in HL-60 leukemia cell membranes, Biochemical Pharmacology, 54, 5, (551), (1997).
  Crossref
• Roger A. Johnson, Robert Alvarez and Yoram Salomon, [3] Determination of adenylyl cyclase catalytic activity using single and double column procedures, Heterotrimeric G-Protein Effectors, 10.1016/0076-6879(94)38005-8, (31-56), (1994).
  Crossref
• Roger A. Johnson and Yoram Salomon, [1] Assay of adenylyl cyclase catalytic activity, Adenylyl Cyclase, G Proteins, and Guanylyl Cyclase, 10.1016/0076-6879(91)95150-I, (3-21), (1991).
  Crossref
• Lutz Birnbaumer, On the Origins and Present State of the Art of G Protein Research, Journal of Receptor Research, 11, 1-4, (577), (1991).
  Crossref
• Hyun Dju Kim, Chapter 6 Ion Transport and Adenylyl Cyclase System in Red Blood Cells, Developmental Biology of Membrane Transport Systems, 10.1016/S0070-2161(08)60804-7, (181-225), (1991).
  Crossref
• Michael W. Martin, José Luis Boyer, John M. May, Lutz Birnbaumer and T. Kendall Harden, Muscarinic Receptors and Their Interactions with G Proteins, G Proteins, 10.1016/B978-0-12-377450-7.50018-6, (317-354), (1990).
  Crossref
• Susan B. Jones and David B. Bylund, Effects of α2-Adrenergic agonist preincubation on subsequent forskolin-stimulated adenylate cyclase activity and [3H]forskolin binding in membranes from HT29 cells, Biochemical Pharmacology, 40, 4, (871), (1990).
  Crossref
• Kevin K. Caldwell, M.Karen Newell, John C. Cambier, Kedar N. Prasad, Joseph M. Masserano, Werner Schlegel and Dermot M.F. Cooper, Evaluation of methods for the isolation of plasma membranes displaying guanosine 5′-triphosphate-dependence for the regulation of adenylate cyclase activity: Potential application to the study of other guanosine 5′-triphosphate-dependent transduction systems, Analytical Biochemistry, 175, 1, (177), (1988).
  Crossref
• Lutz Birnbaumer, Juan Codina, Rafael Mattera, Atsuko Yatani and Arthur M. Brown, Chapter 1 G proteins and transmembrane signalling, Hormones and their Actions Part II - Specific actions of protein hormones, 10.1016/S0167-7306(08)60656-0, (1-46), (1988).
  Crossref
• D.P. Dimitrov and F.R. Bühler, Inhibition of adenylate cyclase activity during the reversible shape change in human platelets, Biochemical and Biophysical Research Communications, 152, 2, (649), (1988).
  Crossref
• Ulrich M. Farack, Rupert Gerzer, Therese M. Keravis and Klaus Loeschke, Discrepancy between effects of cholera toxin on net fluid movement and cAMP levels in rat jejunum, ileum, and colon, Digestive Diseases and Sciences, 33, 9, (1153), (1988).
  Crossref
• FranÇois Lanza, Alain Beretz, Anita Stierlé, Gilles Corre and Jean-Pierre Cazenave, Cyclic nucleotide phosphodiesterase inhibitors prevent aggregation of human platelets by raising cyclic amp and reducing cytoplasmic free calcium mobilization, Thrombosis Research, 45, 5, (477), (1987).
  Crossref
• THÉRÈSE J. RESINK, DIMITAR DIMITROV, AINO ZSCHAUER, PAUL ERNE, VSEVOLOD A. TKACHUK and FRITZ R. BÜHLER, Platelet Calcium‐Linked Abnormalities in Essential Hypertensiona, Annals of the New York Academy of Sciences, 488, 1, (252-265), (2006).
  Wiley Online Library
• Nicolas Ferry, Dominique Henry, Elisabeth Battais, Andrée Mary, Claude Bonne and Jacques Hanoune, Critical assessment of the platelet adenylate cyclase system as a potential model for testing alpha2 adrenergic activity, Biochemical Pharmacology, 35, 9, (1511), (1986).
  Crossref
• Patricia B. Hoyer, Paul Fletcher and Boyd E. Haley, Synthesis of 2′,3′-O-(2,4,6-trinitrocyclohexadienylidine) guanosine 5′-triphosphate and a study of its inhibitory properties with adenylate cyclase, Archives of Biochemistry and Biophysics, 245, 2, (369), (1986).
  Crossref
• THÉRÈSE J. RESINK, DIMITAR DIMITROV, AINO ZSCHAUER, PAUL ERNE, VSEVOLOD A. TKACHUK and FRITZ R. BÜHLER, Platelet Calcium-Linked Abnormalities in Essential Hypertension, Annals of the New York Academy of Sciences, 488, 1 Membrane Path, (252), (1986).
  Crossref
• Klaus Aktories and Karl H. Jakobs, Regulation of Platelet Cyclic AMP Formation, The Platelets, 10.1016/B978-0-12-455555-6.50043-6, (271-288), (1985).
  Crossref
• Maurice B. Feinstein, George B. Zavoico and Stephen P. Halenda, Calcium and Cyclic AMP: Antagonistic Modulators of Platelet Function, The Platelets, 10.1016/B978-0-12-455555-6.50042-4, (237-269), (1985).
  Crossref
• Karl H. JAKOBS, Silvia BAUER and Yasuhiro WATANABE, Modulation of adenylate cyclase of human platelets by phorbol ester, European Journal of Biochemistry, 151, 2, (425-430), (2005).
  Wiley Online Library
• Charles V. Olson, Paula A. Smiley and Pramod M. Lad, Human platelet adenylate cyclase: Persistent binding of guanine nucleotide is central to the regulation of both hormone-stimulated and basal activities, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 845, 3, (411), (1985).
  Crossref
• Narimichi Kimura, Nobuko Shimada and Michio Tsubokura, Adenosine 5′-(β, γ-imino)triphosphate and guanosine 5′-O-(2-thiodiphosphate) do not necessarily provide non-phosphorylating conditions in adenylate cyclase studies, Biochemical and Biophysical Research Communications, 126, 3, (983), (1985).
  Crossref
• Roger Kerry and Michael C. Scrutton, Platelet Adrenoceptors, The Platelets, 10.1016/B978-0-12-455555-6.50037-0, (113-157), (1985).
  Crossref
• L. Birnbaumer, J. Codina, T. Sunyer, W. Rosenthal, J.D. Hildebrandt, R.A. Cerione, M.G. Caron, R.J. Lefkowitz and R.D. Sekura, STRUCTURAL AND FUNCTIONAL PROPERTIES OF NS AND Ni, THE REGULATORY COMPONENTS OF ADENYLYL CYCLASES, Pertussis Toxin, 10.1016/B978-0-12-635480-5.50010-4, (77-104), (1985).
  Crossref
• Klaus AKTORIES and Karl H. JAKOBS, Ni‐mediated inhibition of human platelet adenylate cyclase by thrombin, European Journal of Biochemistry, 145, 2, (333-338), (2005).
  Wiley Online Library
• Johanne Tremblay and Pavel Hamet, Calcium-dependent proteolytic stimulation of adenylate cyclase in platelets from spontaneously hypertensive rats, Metabolism, 33, 8, (689), (1984).
  Crossref
• Kimberley A. Williams and Richard J. Haslam, Effects of NaCl and GTP on the inhibition of platelet adenylate cyclase by 1-O-octadecyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine (synthetic platelet-activating factor), Biochimica et Biophysica Acta (BBA) - Biomembranes, 770, 2, (216), (1984).
  Crossref
• Karl H. JAKOBS, Determination of the Turn‐Off Reaction for the Epinephrine‐Inhibited Human Platelet Adenylate Cyclase, European Journal of Biochemistry, 132, 1, (125-130), (2005).
  Wiley Online Library
• Susanna Colli, Marina Lombroso, Paola Maderna, Elena Tremoli and Simonetta Nicosia, Effects of PGI2 on platelet aggregation and adenylate cyclase activity in human type IIa hypercholesterolemia, Biochemical Pharmacology, 32, 13, (1989), (1983).
  Crossref
• Rong-Tsan Lai, Yasuhiro Watanabe and Hiroshi Yoshida, Effect of islet-activating protein (IAP) on contractile responses of rat vas deferens: Evidence for participation of Ni(inhibitory GTP binding regulating protein) in the α2-adrenoceptor-mediated response, European Journal of Pharmacology, 90, 4, (453), (1983).
  Crossref
• Richard A. Kahn, Toshiaki Katada, Gary M. Bokoch, John K. Northup and Alfred G. Gilman, ADP-RIBOSYLATION OF THE REGULATORY COMPONENTS OF ADENYLATE CYCLASE11This work was supported by United States Public Health Service Grant NS18153 and by a grant (BC240D) from the American Cancer Society.,22A list of abbreviations used, is included at the end of this chapter., Posttranslational Covalent Modifications of Proteins, 10.1016/B978-0-12-387560-0.50028-1, (373-395), (1983).
  Crossref
• Jeffrey M. Stadel and Robert J. Lefkowitz, The β-Adrenergic Receptor: Ligand Binding Studies Illuminate the Mechanism of Receptor-Adenylate Cyclase Coupling, Membrane Receptors, 10.1016/S0070-2161(08)60526-2, (45-66), (1983).
  Crossref
• Karl H Jakobs and Klaus Aktories, Synergistic inhibition of human platelet adenylate cyclase by stable GTP analogs and epinephrine, Biochimica et Biophysica Acta (BBA) - Biomembranes, 732, 2, (352), (1983).
  Crossref
• Karl H. Jakobs, Klaus Aktorie and Günter Schultz, Inhibitory Coupling of Hormone and Neurotransmitter Receptors to Adenylate Cyclase, Journal of Receptor Research, 3, 1-2, (137), (1983).
  Crossref
• David B. Bylund and David C. U'Prichard, Characterization of α1-and α2-Adrenergic Receptors, , 10.1016/S0074-7742(08)60225-1, (343-431), (1983).
  Crossref
• Jean‐Marie Girardot, Jules Kempf and Dermot M. F. Cooper, Role of Calmodulin in the Effect of Guanyl Nucleotides on Rat Hippocampal Adenylate Cyclase: Involvement of Adenosine and Opiates, Journal of Neurochemistry, 41, 3, (848-859), (2006).
  Wiley Online Library
• Dermot M.F. Cooper, Receptor-Mediated Stimulation and Inhibition of Adenylate Cyclase, Membrane Receptors, 10.1016/S0070-2161(08)60527-4, (67-84), (1983).
  Crossref
• Nicole Decker, Gérard Leclerc, Marie-Claude Quennedey, Bruno Rouot and Jean Schwartz, Study of two alkylating derivatives: The p-isothiocyanato- and the p-methylisothiocyanato-clonidine, European Journal of Pharmacology, 93, 3-4, (205), (1983).
  Crossref
• Dermot M.F. Cooper, Bimodal regulation of adenylate cyclase, FEBS Letters, 138, 2, (157-163), (2001).
  Wiley Online Library
• David Lichtstein, Debra Mullikin-Kilpatrick and Arthur J. Blume, Modification of neuroblastoma X glioma hybrid NG108-15 adenylate cyclase by vanadium ions, Biochemical and Biophysical Research Communications, 105, 3, (1157), (1982).
  Crossref
• D.C. U'Prichard, M. Daiguji, C. Tong, J.C. Mitrius and H.Y. Meltzer, α2-ADRENERGIC RECEPTORS: COMPARATIVE BIOCHEMISTRY OF NEURAL AND NON-NEURAL RECEPTORS, AND IN VITRO ANALYSIS IN PSYCHIATRIC PATIENTS, Biological Markers in Psychiatry and Neurology, 10.1016/B978-0-08-027987-9.50026-3, (205-217), (1982).
  Crossref
• Marc Laburthe, Brigitte Amiranoff and Claudine Boissard, α-Adrenergic inhibition of cyclic AMP accumulation in epithelial cells isolated from rat small intestine, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 721, 1, (101), (1982).
  Crossref
• Thomas Michel, Brian B. Hoffman and Robert J. Lefkowitz, Regulation of Adenylate Cyclase by Adrenergic Receptors, Biochemical Actions of Hormones, 10.1016/B978-0-12-452809-3.50007-5, (43-68), (1982).
  Crossref
• Daphne ATLAS and Steven L. SABOL, Interaction of Clonidine and Clonidine Analogues with α‐Adrenergic Receptors of Neuroblastoma × Glioma Hybrid Cells and Rat Brain, European Journal of Biochemistry, 113, 3, (521-529), (2005).
  Wiley Online Library
• Thomas Michel, Brian B. Hoffman, Robert J. Lefkowitz and Marc G. Caron, Different sedimentation properties of agonist- and antagonist-labelled platelet alpha2 adrenergic receptors, Biochemical and Biophysical Research Communications, 100, 3, (1131), (1981).
  Crossref
• Brian B. Hoffman, Susan Yim, Bie Shung Tsai and Robert J. Lefkowitz, Preferential uncoupling by manganese of alpha adrenergic receptor mediated inhibition of adenylate cyclase in human platelets, Biochemical and Biophysical Research Communications, 100, 2, (724), (1981).
  Crossref
• Tatsuya Haga and Kazuko Haga, Characterization by [3H]Dihydroergocryptine Binding of Alpha‐Adrenergic Receptors in Neuroblastoma × Glioma Hybrid Cells, Journal of Neurochemistry, 36, 3, (1152-1159), (2006).
  Wiley Online Library
• Friedrich Propst and Bernd Hamprecht, Opioids, Noradrenaline and GTP Analogs Inhibit Cholera Toxin Activated Adenylate Cyclase in Neuroblastoma × Glioma Hybrid Cells, Journal of Neurochemistry, 36, 2, (580-588), (2006).
  Wiley Online Library
• Klaus Aktories and Karl H. Jakobs, Epinephrine inhibits adenylate cyclase and stimulates a GTPase in human platelet membranes vis α‐adrenoceptors, FEBS Letters, 130, 2, (235-238), (2001).
  Wiley Online Library
• John H. Exton, Molecular mechanisms involved in α-adrenergic responses, Molecular and Cellular Endocrinology, 23, 3, (233), (1981).
  Crossref
• Lawrence E. Cornett, Don W. Ball and James S. Norris, α1-Adrenergic Receptors of A Smooth Muscle Cell Line: Guanine Nucleotides Do Not Regulate Agonist Affinities, Journal of Receptor Research, 2, 5-6, (601), (1981).
  Crossref
• K. Aktories, K.H. Jakobs and G. Schultz, Nicotinic acid inhibits adipocyte adenylate cyclase in a hormone—like manner, FEBS Letters, 115, 1, (11-14), (2001).
  Wiley Online Library
• Bruno M. Rouot, David C. U'Prichard and Solomon H. Snyder, Multiple α2‐Noradrenergic Receptor Sites in Rat Brain: Selective Regulation of High‐Affinity [3H] Clonidine Binding by Guanine Nucleotides and Divalent Cations, Journal of Neurochemistry, 34, 2, (374-384), (2006).
  Wiley Online Library
• Daniel H. Desmedt, Catecholamine action on thyroid adenylate cyclase: evidence for inhibitory α-adrenoreceptors, Biochemical Pharmacology, 29, 13, (1966), (1980).
  Crossref
• Klaus P. Mellwig and Karl H. Jakobs, Inhibition of platelet adenylate cyclase by ADP, Thrombosis Research, 18, 1-2, (7), (1980).
  Crossref
• Werner Schlegel, Dermot M.F. Cooper and Martin Rodbell, Inhibition and activation of fat cell adenylate cyclase by GTP is mediated by structures of different size, Archives of Biochemistry and Biophysics, 201, 2, (678), (1980).
  Crossref
• Klaus Aktories, G�nter Schultz and Karl H. Jakobs, Regulation of adenylate cyclase activity in hamster adipocytes, Naunyn-Schmiedeberg's Archives of Pharmacology, 312, 2, (167), (1980).
  Crossref
• Stein Ove Døskeland, Guanine nucleotides protect adenylate cyclase against inhibition by Pb2+, Biochimica et Biophysica Acta (BBA) - General Subjects, 630, 1, (15), (1980).
  Crossref
• J. H. Exton, Mechanisms involved in alpha-adrenergic phenomena: role of calcium ions in actions of catecholamines in liver and other tissues, American Journal of Physiology-Endocrinology and Metabolism, 238, 1, (E3), (1980).
  Crossref
• J. Adolfo García-Sáinz, Brian B. Hoffman, Shih-Ying Li, Robert J. Lefkowitz and John N. Fain, Role of alpha1 adrenoceptors in the turnover of phosphatidylinositol and of alpha2 adrenoceptors in the regulation of cyclic AMP accumulation in hamster adipocytes, Life Sciences, 27, 11, (953), (1980).
  Crossref
• Douglas Wilkening, Steven L. Sabol and Marshall Nirenberg, Control of opiate receptor-adenylate cyclase interactions by calcium ions and guanosine-5′-triphosphate, Brain Research, 189, 2, (459), (1980).
  Crossref
• TAMAS BARTFAI, Cyclic Nucleotides in the Central Nervous System, , 10.1016/B978-0-12-152816-4.50011-X, (225-269), (1980).
  Crossref
• John N. Fain and J.Adolfo García-Sáinz, Role of phosphatidylinositol turnover in alpha1 and of adenylate cyclase inhibition in alpha2 effects of catecholamines, Life Sciences, 26, 15, (1183), (1980).
  Crossref
• Klaus Aktories, Günter Schultz and Karl H. Jakobs, Inhibition of hamster fat cell adenylate cyclase by prostaglandin E1 and epinephrine: Requirement for GTP and sodium ions, FEBS Letters, 107, 1, (100-104), (2001).
  Wiley Online Library
• Peter Lasch and Karl H. Jakobs, Agonistic and antagonistic effects of various ?-adrenergic agonists in human platelets, Naunyn-Schmiedeberg's Archives of Pharmacology, 306, 2, (119), (1979).
  Crossref
• Dermot M. F. Cooper and Martin Rodbell, ADP is a potent inhibitor of human platelet plasma membrane adenylate cyclase, Nature, 282, 5738, (517), (1979).
  Crossref
• Karl H. Jakobs and G�nter Schultz, Different inhibitory effect of adrenaline on platelet adenylate cyclase in the presence of GTP plus cholera toxin and of stable GTP analogues, Naunyn-Schmiedeberg's Archives of Pharmacology, 310, 2, (121), (1979).
  Crossref
• JACQUELINE A. GRANT and MICHAEL C. SCRUTTON, Novel α2-adrenoreceptors primarily responsible for inducing human platelet aggregation, Nature, 277, 5698, (659), (1979).
  Crossref
• Karl H. Jakobs, Klaus Aktories and G�nter Schultz, GTP-dependent inhibition of cardiac adenylate cyclase by muscarinic cholinergic agonists, Naunyn-Schmiedeberg's Archives of Pharmacology, 310, 2, (113), (1979).
  Crossref
• Bie Shung Tsai and Robert J. Lefkowitz, Multiple effects of guanine nucleotides on human platelet adenylate cyclase, Biochimica et Biophysica Acta (BBA) - General Subjects, 587, 1, (28), (1979).
  Crossref
• KARL H. JAKOBS, Synthetic α-adrenergic agonists are potent α-adrenergic blockers in human platelets, Nature, 274, 5673, (819), (1978).
  Crossref
• K. H. Jakobs and R. Rauschek, [3H]Dihydroergonine binding to ?-adrenergic receptors in human platelets, Klinische Wochenschrift, 56, S1, (139), (1978).
  Crossref